| GMVAX | VEXAX | GMVAX / VEXAX | |
| Total Expense Ratio | 1.17 | 0.05 | 2,340% |
| Annual Report Gross Expense Ratio | 1.45 | 0.05 | 2,900% |
| Fund Existence | 13 years | 26 years | - |
| Gain YTD | 16.554 | 13.061 | 127% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 151M | 97.7B | 0% |
| Annual Yield % from dividends | 0.00 | 1.03 | - |
| Returns for 1 year | 16.84 | 19.75 | 85% |
| Returns for 3 years | 28.94 | 51.91 | 56% |
| Returns for 5 years | 15.98 | 28.28 | 57% |
| Returns for 10 years | 82.39 | 175.82 | 47% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PZVNX | 16.06 | 0.17 | +1.07% |
| Pzena International Value Investor | |||
| RWICX | 80.16 | 0.72 | +0.91% |
| American Funds Cptl Wld Gr&Inc R-3 | |||
| HESGX | 44.91 | 0.36 | +0.81% |
| Horizon Defensive Core Investor | |||
| TRSSX | 27.61 | -0.22 | -0.79% |
| T. Rowe Price Instl Small-Cap Stock | |||
| BISAX | 27.40 | -0.22 | -0.80% |
| Brandes International Small Cap Equity A | |||